Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
NEW DELHI, April 21 (Reuters) - The Serum Institute of India said on Wednesday it would sell the AstraZeneca vaccine to the country's state governments at 400 rupees ($5.30) per dose and to private hospitals at 600 rupees ($7.95)."Furthermore, owi...
Read more(Adds details on class of vaccines)By John MillerZURICH, April 20 (Reuters) - A German scientist studying extremely rare blood clots linked to AstraZeneca's COVID-19 vaccine said on Tuesday Johnson & Johnson has agreed to work with him on the rese...
Read more(Adds details of collaboration, scientific paper)By John MillerZURICH, April 20 (Reuters) - A German scientist studying extremely rare blood clots linked to AstraZeneca's COVID-19 vaccine said on Tuesday Johnson & Johnson has agreed to work with h...
Read moreZURICH, April 20 (Reuters) - A German scientist studying rare blood clots linked to AstraZeneca's COVID-19 vaccine said on Tuesday that Johnson & Johnson had agreed to collaborate with him on research into similar events associated with its own C...
Read moreAMSTERDAM, April 20 (Reuters) - The European Union's drug regulator said on Tuesday there had been more than 300 cases worldwide of rare blood clotting incidents combined with low platelet counts after use of COVID-19 vaccines.There were 287 occur...
Read more(Adds details on Mexico vaccine supply)By Daina Beth SolomonMEXICO CITY, April 20 (Reuters) - Mexican President Andres Manuel Lopez Obrador received the AstraZeneca shot against COVID-19 on Tuesday, urging trust in vaccines after several countries...
Read more(Adds context on AstraZeneca, quotes)MEXICO CITY, April 20 (Reuters) - Mexican President Andres Manuel Lopez Obrador received the AstraZeneca shot against COVID-19 on Tuesday, urging trust in vaccines after several countries limited the use of Ast...
Read more* EMA assessed 8 cases of serious clots in the United States* Says overall benefits outweigh any risks* Cases occurred in adults under 60, most of them women (Adding details throughout)By Pushkala Aripaka, Anthony Deutsch and John MillerApril 20 (Re...
Read more* EMA assessed 8 cases of serious clots in the United States* Says overall benefits outweigh any risks* Cases occurred in adults under 60, most of them women (Adds details, quotes from EMA news conference)By Pushkala Aripaka and Anthony DeutschApril...
Read more* EMA assessed 8 cases of serious clots in the United States* Says overall benefits outweigh any risks* Cases occurred in adults under 60, most of them women (Writes through with details, background)April 20 (Reuters) - Europe's drug regulator has f...
Read more(Adds details from EMA statement)April 20 (Reuters) - Europe's drug regulator said on Tuesday it had found a possible link between Johnson & Johnson's COVID-19 vaccine and rare blood clotting issues in adults who had received the shot in the Unite...
Read more* EMA assessed 8 cases of serious clots in the United States* Says overall benefits outweigh any risks* Cases occurred in adults under 60, most of them women (Adds details throughout)By Pushkala Aripaka, Anthony Deutsch and John MillerApril 20 (Reut...
Read moreMEXICO CITY, April 20 (Reuters) - Mexican President Andres Manuel Lopez Obrador received the AstraZeneca vaccine against COVID-19 at his regular daily news conference on Tuesday.The 67-year-old, who had contracted the coronavirus in January, said ...
Read moreApril 20 (Reuters) - Europe's drug regulator has found a possible link between Johnson & Johnson's COVID-19 vaccine and rare blood clotting issues in adults who had received the shot in the United States, the watchdog said on Tuesday.(Reporting b...
Read more* Alpine nation has approved 3 COVID-19 vaccines, so far* Swiss expect 8 mln Q2 vaccine doses, despite Moderna hiccups (Adds detail in 6th paragraph about possible recommendation for AstraZeneca vaccine, following rare blood clots)By John MillerZU...
Read more
Last checked at